Factors | Resistance to any drug (n = 381) | MDR-TB (n = 183) | Pan-susceptible TB (n = 411) | MDR-TB vs Pan-susceptible TB | Resistance to any drug vs Pan-susceptible TB | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Odds ratio (95 % CI) | P value | Adjusted odds ratio (95 % CI) | P value | Odds ratio (95 % CI) | P value | Adjusted odds ratio (95 % CI) | P value | ||||
Gender | |||||||||||
Male | 289 | 131 | 297 | Reference | Reference | ||||||
Female | 92 | 52 | 114 | 1.03 (0.70–1.52) | 0.865 | 0.83 (0.60–1.14) | 0.250 | ||||
Age group (years) | |||||||||||
~25 | 60 | 38 | 57 | Reference | Reference | Reference | Reference | ||||
~44 | 105 | 64 | 80 | 1.20 (0.71–2.03) | 0.892 | 1.05 (0.51–2.19) | 0.718 | 1.25 (0.78–1.99) | 0.734 | 1.09 (0.65–1.83) | 0.625 |
~64 | 145 | 66 | 132 | 0.75 (0.45–1.24) | 0.155 | 0.60 (0.30–1.21) | 0.033 | 1.04 (0.68–1.61) | 0.969 | 0.99 (0.61–1.60) | 0.610 |
>64 | 71 | 15 | 142 | 0.16 (0.08–0.31) | <0.001 | 0.12 (0.05–0.27) | <0.001 | 0.48 (0.30–0.75) | 0.011 | 0.52 (0.31–0.86) | 0.002 |
Treatment history | |||||||||||
New cases | 152 | 26 | 342 | Reference | Reference | Reference | Reference | ||||
Previously treated cases | 229 | 157 | 69 | 29.93 (18.35–48.81) | <0.001 | 32.64 (19.40–54.92) | <0.001 | 7.47 (5.37–10.39) | <0.001 | 7.11 (5.09–9.92) | <0.001 |